Biologic Therapy Carries a Very Low Risk of Reactivation in Hepatitis B Surface Antigen-Negative Phase of Hepatitis B.

Ergenç, İlkay; Kani, HALUK; Karabacak, Murat; Cömert Özer, Elif; Mehdiyev, Shahin; Jafarov, Fuad; Abacar, Kerem; Kutluğ Ağaçkıran, Seda; Sevik, Gizem; Aslan, Rahmi; Alibaz Öner, FATMA; İnanç, Nevsun; Atagündüz, MEHMET; Seçkin, Dilek; Özen Alahdab, Yeşim; Ergun, Tülin; Direskeneli, RAFİ; Atuğ, Özlen

doi:10.5152/tjg.2022.22196

Biologic Therapy Carries a Very Low Risk of Reactivation in Hepatitis B Surface Antigen-Negative Phase of Hepatitis B.

Ergenç İ., Kani H. T., Karabacak M., Cömert Özer E., Mehdiyev S., Jafarov F., ...More

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, vol.34, no.2, pp.156-160, 2023 (SCI-Expanded)

Publication Type: Article / Article
Volume: 34 Issue: 2
Publication Date: 2023
Doi Number: 10.5152/tjg.2022.22196
Journal Name: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, MEDLINE, TR DİZİN (ULAKBİM)
Page Numbers: pp.156-160
Keywords: Anti-HBc IgG, anti-TNF, biologic agents, hepatitis B, reactivation, VIRUS HBV REACTIVATION, RHEUMATIC PATIENTS, INFECTION, SAFETY, HBSAG
Marmara University Affiliated: Yes

Abstract

Background: The risk of hepatitis B reactivation in hepatitis B surface antigen-negative phase of hepatitis B virus-infected patients exposed to biologic agents is not clear. We aimed to investigate the reactivation rate in hepatitis B surface antigen-negative phase of hepatitis B virus-infected patients after biologic therapy.